StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note published on Monday. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright restated a “buy” rating and set a $7.00 price target on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Price Performance

Shares of Aethlon Medical stock opened at $0.74 on Monday. Aethlon Medical has a one year low of $0.24 and a one year high of $1.88. The business’s 50 day simple moving average is $0.56 and its two-hundred day simple moving average is $0.45. The stock has a market capitalization of $10.35 million, a P/E ratio of -0.26 and a beta of 1.61.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.